{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:08:57Z","timestamp":1791022137177,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.neurobiolaging.2004.02.011","type":"journal-article","created":{"date-parts":[[2004,5,12]],"date-time":"2004-05-12T10:25:58Z","timestamp":1084357558000},"page":"1293-1298","source":"Crossref","is-referenced-by-count":65,"title":["Association between the interleukin-1\u03b1 gene and Alzheimer\u2019s disease: a meta-analysis"],"prefix":"10.1016","volume":"25","author":[{"given":"I.","family":"Rainero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Valfr\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Vaula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pinessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1359-6101(02)00020-5","article-title":"The balance between IL-1 and IL-1Ra in disease","volume":"13","author":"Arend","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB2","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s00415-002-0819-9","article-title":"Gene dose-dependent association of interleukin-1A (\u2212889) allele polymorphism with Alzheimer\u2019s disease","volume":"249","author":"Combarros","year":"2002","journal-title":"J. Neurol"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0896-6273(95)90300-3","article-title":"Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1","volume":"14","author":"Das","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00251-002-0445-9","article-title":"Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha","volume":"54","author":"Dominici","year":"2002","journal-title":"Immunogenetics"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB5","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1212\/WNL.55.4.480","article-title":"Griffin WS.T., Association of interleukin 1\u03b1 polymorphism with Alzheimer\u2019s disease","volume":"55","author":"Du","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0197-4580(96)00108-X","article-title":"The role of complement and activated microglia in the pathogenesis of Alzheimer\u2019s disease","volume":"17","author":"Eikelenboom","year":"1996","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB7","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1073\/pnas.86.19.7606","article-title":"Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells","volume":"86","author":"Goldgaber","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB8","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1212\/WNL.58.10.1566","article-title":"Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD?","volume":"58","author":"Green","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0531-5565(00)00110-8","article-title":"The pervasiveness of interleukin-1 in Alzheimer pathogenesis: a role for specific polymorphisms in disease risk","volume":"35","author":"Griffin","year":"2000","journal-title":"Exp. Gerontol"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00005072-199503000-00014","article-title":"Interleukin-1 expression in different plaque types in Alzheimer\u2019s disease: significance in plaque evolution","volume":"54","author":"Griffin","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO;2-N","article-title":"Association of early-onset Alzheimer\u2019s disease with an interleukin-1\u03b1 gene polymorphism","volume":"47","author":"Grimaldi","year":"2000","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ana.10196","article-title":"Association of interleukin-1 polymorphisms with Alzheimer\u2019s Disease in Australia","volume":"51","author":"Hedley","year":"2002","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/ana.1067","article-title":"Lack of association of the interleukin-1\u03b1 gene polymorphism with Alzheimer\u2019s Disease in a Korean Population","volume":"49","author":"Ki","year":"2001","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00002093-200304000-00007","article-title":"Lack of association between interleukin-1\u03b1 polymorphism and Alzheimer disease or vascular dementia","volume":"17","author":"Kuo","year":"2003","journal-title":"Alzheimer Dis. Associated Disorders"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1523\/JNEUROSCI.20-01-00149.2000","article-title":"Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression","volume":"20","author":"Li","year":"2000","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB16","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/1531-8249(200011)48:5<817::AID-ANA22>3.0.CO;2-S","article-title":"Genetic association studies of interleukin-1 (IL-1A and IL-1B) and interleukin-1 receptor antagonist genes and risk of Alzheimer\u2019s disease","volume":"48","author":"Minster","year":"2000","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB18","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0197-4580(01)00287-1","article-title":"Interleukin-1, neuroinflammation, and Alzheimer\u2019s disease","volume":"22","author":"Mrak","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G","article-title":"Association of Interleukin-1 gene polymorphisms with Alzheimer\u2019s disease","volume":"47","author":"Nicoll","year":"2000","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1749-6632.2003.tb03136.x","article-title":"Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration","volume":"992","author":"Patel","year":"2003","journal-title":"Ann. NY Acad. Sci"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000063603","article-title":"Interleukin 1 alpha gene polymorphism as a susceptibility factor in Alzheimer\u2019s Disease and its influence on the extent of histopathological hallmark lesions of Alzheimer\u2019s Disease","volume":"14","author":"Pirskanen","year":"2002","journal-title":"Dement. Geriat. Cogn. Disord"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0304-3940(00)01487-7","article-title":"Confirmation of the genetic association of interleukin-1 A with early onset sporadic Alzheimer\u2019s disease","volume":"293","author":"Rebeck","year":"2000","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0197-4580(96)00115-7","article-title":"Inflammation and Alzheimer\u2019s disease pathogenesis","volume":"17","author":"Rogers","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0165-6147(91)90623-Z","article-title":"Functions and mechanisms of interleukin 1 in the brain","volume":"12","author":"Rothwell","year":"1991","journal-title":"Trends Pharmacol. Sci"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0166-2236(00)01661-1","article-title":"Interleukin 1 in the brain: biology, pathology and therapeutic target","volume":"23","author":"Rothwell","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB26","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2990.1998.00122.x","article-title":"Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer\u2019s disease","volume":"24","author":"Sheng","year":"1998","journal-title":"Neuropathol. Appl. Neurobiol"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB27","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1177\/00220345000790110801","article-title":"Polymorphisms in the IL-1A gene are correlated with levels of interlukin-1alpha protein in gingival cervicular fluid of teeth with severe periodontal disease","volume":"79","author":"Shirodaria","year":"2000","journal-title":"J. Dent. Res"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB28","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0197-4580(01)00290-1","article-title":"Chemokines and Alzheimer\u2019s disease","volume":"22","author":"Streit","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB29","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1006\/geno.2002.6752","article-title":"Genomic organization of the interleukin-1 locus","volume":"79","author":"Taylor","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.neurobiolaging.2004.02.011_BIB30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0304-3940(03)00333-1","article-title":"Lack of association between the interleukin-1 alpha gene C (\u2212889) T polymorphism and Alzheimer\u2019s disease in a Chinese population","volume":"343","author":"Tsai","year":"2003","journal-title":"Neurosci. Lett"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458004001101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458004001101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T13:53:30Z","timestamp":1549720410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458004001101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0197458004001101"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.02.011","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}